Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Welling Health vs YourHealthRx

Welling Health
Graded #149

Lower grade

vs+1.2999999999999972
YourHealthRx
Graded #119

Higher grade

The verdict

YourHealthRx takes it — 69.6/100 to 68.3/100, but only just.

YourHealthRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Welling Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWelling Health +3
56
53
Dose & formulationYourHealthRx +11
64
75
Clinical oversightWelling Health +2
89
87
Labs & monitoringYourHealthRx +13
54
67
FulfillmentYourHealthRx +1
93
94
Contract termsWelling Health +22
55
33
Welling Health · left barYourHealthRx · right bar

The numbers

MetricWelling HealthYourHealthRx
WeighScore68.3/10069.6/100
GradeCC
Scorecard rank#149#119
Semaglutide$190/mo (compounded)$170/mo (compounded)
Tirzepatide$275/mo (compounded)$210/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Welling Health

Graded #149 · C

Strengths

  • Transparent flat monthly rate — $190 semaglutide / $275 tirzepatide, all doses, no insurance or hidden fees
  • LegitScript-certified 503A pharmacy with US-licensed clinicians in all 50 states and a named legal entity
  • Streak discounts cut up to 30% — semaglutide as low as $133/month for logging meals consistently
  • Free shipping, free AI macro-tracker app, and 24-hour intake review

Where it loses points

  • Tirzepatide at $275/month is higher than the cheapest compounded competitors
  • The streak discount requires daily in-app meal logging — miss days and you pay full rate
  • The compounding pharmacy partner is described as a LegitScript-certified 503A but not named
  • Only two medications — compounded semaglutide and tirzepatide; no oral or non-GLP options
YourHealthRx

Graded #119 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard